UPS opens healthcare and life-sciences centre at Schiphol

default_image

© Khunaspix Dreamstime.

By LoadstarEditorial

12/05/2015

Investment supports growing customer demand for temperature-controlled product handling and strengthens UPS’s position in pharmaceutical air freight transportation

London, May 12, 2015 – UPS® (NYSE: UPS) today announced the expansion of its temperature-controlled supply chain capabilities in Europe with the opening of a healthcare-dedicated air freight forwarding facility at Amsterdam Airport Schiphol, Netherlands. The opening demonstrates UPS’s continued investment for growth in specialised market segments, in this case, for logistics needs of healthcare and life-sciences companies in the region.

Read more...

Comment on this article

You must be logged in to post a comment.

Topics

pharma pharmaceutical logistics

Most read news

Etail by air – here to stay or on a short shelf life?

HMM sees opportunities in Hapag-Lloyd’s exit from THE Alliance

How crazy is this: DSV goes hostile on Expeditors or CH Robinson?

The rise and rise of China's ecommerce platforms

Increasing scrutiny could stall rise of ecommerce platforms, as TikTok faces US ban

Liners unveil Asia-Europe FAK price hikes to arrest steady rate decline

Legal battle heats up over 'unseaworthy' and 'reckless' MV Dali

Another strong month for US ports as container flows continue to rise

DSV chief reticent on Schenker: the focus on growing market share

MSC redeploys 'Israel-linked' box ships away from Persian Gulf

Boxes piling into Mexican ports – but then piling up

Liners add capacity to Asia-ECSA as ocean rates hit 18-month high

Evergreen clients signing transpac contracts as Red Sea crisis props up rates

WSC asks US court to order FMC to correct 'inconsistent' new D&D rules

K+N looks past Q1 revenue drop to improved margins from restructure

US intermodal picking up steam as trucking woes continue